1h Free Analyst Time
The publisher has been monitoring the in-vitro toxicity testing market and it is poised to grow by $5.18 bn during 2022-2026 progressing at a CAGR of 10.09% during the forecast period. The report on the in-vitro toxicity testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing use of in-vitro toxicity testing by companies to reduce drug failures and the presence of toxic substances.
The in-vitro toxicity testing market analysis includes the end-user segment and geographic landscape.
The in-vitro toxicity testing market is segmented as below:
By End-user
- Pharmaceutical and biotechnology companies
- Academic and research institutions
- Others
By Geographical Landscape
- North America
- Europe
- Asia
- ROW
This study identifies the rising number of awareness programs as one of the prime reasons driving the in-vitro toxicity testing market growth during the next few years.
The report on in-vitro toxicity testing market covers the following areas:
- In-vitro toxicity testing market sizing
- In-vitro toxicity testing market forecast
- In-vitro toxicity testing market industry analysis
The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading in-vitro toxicity testing market vendors that include Abbott Laboratories, Agilent Technologies Inc., Bio Rad Laboratories Inc., Charles River Laboratories International Inc., Eurofins Scientific SE, Evotec SE, Laboratory Corp. of America Holdings, Merck KGaA, SGS SA, and Thermo Fisher Scientific Inc. Also, the in-vitro toxicity testing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1. Executive Summary1.1 Market overview
2. Market Landscape
2.1 Market ecosystem
Exhibit 08: Parent market
Exhibit 09: Market characteristics
2.2 Value chain analysis
Exhibit 10: Value chain analysis - Life sciences tools and services
2.2.1Research and development
2.2.2 Inputs
2.2.3 Production
2.2.5 Marketing and sales
2.2.6 Post-sales and services
2.2.7 Industry innovations
3. Market Sizing
3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021 - 2026
Exhibit 13: Global - Market size and forecast 2021 - 2026 ($ million)
Exhibit 14: Global market: Year-over-year growth 2021-2026 (%)
4. Five Forces Analysis
4.1 Five Forces Summary
Exhibit 15: Five forces analysis 2021 & 2026
4.2 Bargaining power of buyers
Exhibit 16: Bargaining power of buyers
4.3 Bargaining power of suppliers
Exhibit 17: Bargaining power of suppliers
4.4 Threat of new entrants
Exhibit 18: Threat of new entrants
4.5 Threat of substitutes
Exhibit 19: Threat of substitutes
4.6 Threat of rivalry
Exhibit 20: Threat of rivalry
4.7 Market condition
Exhibit 21: Market condition - Five forces 2021
5. Market Segmentation by End-user
5.1 Market segments
Exhibit 22: End-user - Market share 2021-2026 (%)
5.2 Comparison by End-user
Exhibit 23: Comparison by end-user
5.3 Pharmaceutical and biotechnology companies - Market size and forecast 2021-2026
Exhibit 24: Pharmaceutical and biotechnology companies - Market size and forecast 2021-2026 ($ million)
Exhibit 25: Pharmaceutical and biotechnology companies - Year-over-year growth 2021-2026 (%)
5.4 Academic and research institutions - Market size and forecast 2021-2026
Exhibit 26: Academic and research institutions - Market size and forecast 2021-2026 ($ million)
Exhibit 27: Academic and research institutions - Year-over-year growth 2021-2026 (%)
5.5 Others - Market size and forecast 2021-2026
Exhibit 28: Others - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Others - Year-over-year growth 2021-2026 (%)
5.6 Market opportunity by end-user
Exhibit 30: Market opportunity by end-user
6. Customer landscape
6.1 Overview
Exhibit 31: Customer landscape
7. Geographic Landscape
7.1 Geographic segmentation
Exhibit 32: Market share By Geographical Landscape 2021-2026 (%)
7.2 Geographic comparison
Exhibit 33: Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 34: North America - Market size and forecast 2021-2026 ($ million)
Exhibit 35: North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
Exhibit 36: Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 37: Europe - Year-over-year growth 2021-2026 (%)
7.5 Asia - Market size and forecast 2021-2026
Exhibit 38: Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 39: Asia - Year-over-year growth 2021-2026 (%)
7.6 ROW - Market size and forecast 2021-2026
Exhibit 40: ROW - Market size and forecast 2021-2026 ($ million)
Exhibit 41: ROW - Year-over-year growth 2021-2026 (%)
7.7 Key leading countries
Exhibit 42: Key leading countries
7.8 Market opportunity By Geographical Landscape
Exhibit 43: Market opportunity By Geographical Landscape ($ million)
8. Drivers, Challenges, and Trends
8.1 Market drivers
8.1.1 Increasing use of in-vitro toxicity testing by companies to reduce drug failures
8.1.2 Presence of toxic substances
8.1.3 Rising number of awareness programs
8.2 Market challenges
8.2.1 Limitations of preclinical studies
8.2.2 Limited number of skilled professionals
8.2.3 Presence of stringent regulations
Exhibit 44: Impact of drivers and challenges
8.3 Market trends
8.3.1 Advances in toxicology
8.3.2 Surge in demand for cosmetics
8.3.3 Increasing investments in drug discovery
9. Vendor Landscape
9.1 Overview
Exhibit 45: Vendor landscape
9.2 Landscape disruption
Exhibit 46: Landscape disruption
Exhibit 47: Industry risks
9.3 Competitive scenario
10. Vendor Analysis
10.1 Vendors covered
Exhibit 48: Vendors covered
10.2 Market positioning of vendors
Exhibit 49: Market positioning of vendors
10.3 Abbott Laboratories
Exhibit 50: Abbott Laboratories - Overview
Exhibit 51: Abbott Laboratories - Business segments
Exhibit 52: Abbott Laboratories - Key news
Exhibit 53: Abbott Laboratories - Key offerings
Exhibit 54: Abbott Laboratories - Segment focus
10.4 Agilent Technologies Inc.
Exhibit 55: Agilent Technologies Inc. - Overview
Exhibit 56: Agilent Technologies Inc. - Business segments
Exhibit 57: Agilent Technologies Inc. - Key news
Exhibit 58: Agilent Technologies Inc. - Key offerings
Exhibit 59: Agilent Technologies Inc. - Segment focus
10.5 Bio Rad Laboratories Inc.
Exhibit 60: Bio Rad Laboratories Inc. - Overview
Exhibit 61: Bio Rad Laboratories Inc. - Business segments
Exhibit 62: Bio Rad Laboratories Inc. - Key news
Exhibit 63: Bio Rad Laboratories Inc. - Key offerings
Exhibit 64: Bio Rad Laboratories Inc. - Segment focus
10.6 Charles River Laboratories International Inc.
Exhibit 65: Charles River Laboratories International Inc. - Overview
Exhibit 66: Charles River Laboratories International Inc. - Business segments
Exhibit 67: Charles River Laboratories International Inc. - Key offerings
Exhibit 68: Charles River Laboratories International Inc. - Segment focus
10.7 Eurofins Scientific SE
Exhibit 69: Eurofins Scientific SE - Overview
Exhibit 70: Eurofins Scientific SE - Business segments
Exhibit 71: Eurofins Scientific SE - Key news
Exhibit 72: Eurofins Scientific SE - Key offerings
Exhibit 73: Eurofins Scientific SE - Segment focus
10.8 Evotec SE
Exhibit 74: Evotec SE - Overview
Exhibit 75: Evotec SE - Business segments
Exhibit 76: Evotec SE - Key offerings
Exhibit 77: Evotec SE - Segment focus
10.9 Laboratory Corp. of America Holdings
Exhibit 78: Laboratory Corp. of America Holdings - Overview
Exhibit 79: Laboratory Corp. of America Holdings - Business segments
Exhibit 80: Laboratory Corp. of America Holdings - Key offerings
Exhibit 81: Laboratory Corp. of America Holdings - Segment focus
10.10 Merck KGaA
Exhibit 82: Merck KGaA - Overview
Exhibit 83: Merck KGaA - Business segments
Exhibit 84: Merck KGaA- Key news
Exhibit 85: Merck KGaA - Key offerings
Exhibit 86: Merck KGaA - Segment focus
10.11 SGS SA
Exhibit 87: SGS SA - Overview
Exhibit 89: SGS SA - Key news
Exhibit 90: SGS SA - Key offerings
Exhibit 91: SGS SA - Segment focus
10.12 Thermo Fisher Scientific Inc.
Exhibit 92: Thermo Fisher Scientific Inc. - Overview
Exhibit 93: Thermo Fisher Scientific Inc. - Business segments
Exhibit 94: Thermo Fisher Scientific Inc. - Key news
Exhibit 95: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 96: Thermo Fisher Scientific Inc. - Segment focus
11. Appendix
11.1 Scope of the report
11.1.1 Definition
11.1.2 Objectives
11.1.3 Notes and caveats
11.2 Currency conversion rates for US$
Exhibit 97: Currency conversion rates for US$
11.3 Research Methodology
Exhibit 98: Research Methodology
Exhibit 99: Validation techniques employed for market sizing
Exhibit 100: Information sources
11.4 List of abbreviations
Exhibit 101: List of abbreviations
List of ExhibitsExhibits 1: Key Finding 1
Exhibits 2: Key Finding 2
Exhibits 3: Key Finding 3
Exhibits 4: Key Finding 5
Exhibits 5: Key Finding 6
Exhibits 6: Key Finding 7
Exhibits 7: Key Finding 8
Exhibits 8: Parent market
Exhibits 9: Market characteristics
Exhibits 10: Offerings of vendors included in the market definition
Exhibits 11: Market segments
Exhibits 12: Global - Market size and forecast 2021 - 2026 ($ million)
Exhibits 13: Global market: Year-over-year growth 2021 - 2026 (%)
Exhibits 14: Five forces analysis 2021 & 2026
Exhibits 15: Bargaining power of buyers
Exhibits 16: Bargaining power of suppliers
Exhibits 17: Threat of new entrants
Exhibits 18: Threat of substitutes
Exhibits 19: Threat of rivalry
Exhibits 20: Market condition - Five forces 2021
Exhibits 21: End-user - Market share 2021-2026 (%)
Exhibits 22: Comparison by End-user
Exhibits 23: Pharmaceutical and biotechnology companies - Market size and forecast 2021-2026 ($ million)
Exhibits 24: Pharmaceutical and biotechnology companies - Year-over-year growth 2021-2026 (%)
Exhibits 25: Academic and research institutions - Market size and forecast 2021-2026 ($ million)
Exhibits 26: Academic and research institutions - Year-over-year growth 2021-2026 (%)
Exhibits 27: Others - Market size and forecast 2021-2026 ($ million)
Exhibits 28: Others - Year-over-year growth 2021-2026 (%)
Exhibits 29: Market opportunity by End-user
Exhibits 30: Customer landscape
Exhibits 31: Market share By Geographical Landscape 2021-2026 (%)
Exhibits 32: Geographic comparison
Exhibits 33: North America - Market size and forecast 2021-2026 ($ million)
Exhibits 34: North America - Year-over-year growth 2021-2026 (%)
Exhibits 35: Europe - Market size and forecast 2021-2026 ($ million)
Exhibits 36: Europe - Year-over-year growth 2021-2026 (%)
Exhibits 37: Asia - Market size and forecast 2021-2026 ($ million)
Exhibits 38: Asia - Year-over-year growth 2021-2026 (%)
Exhibits 39: ROW - Market size and forecast 2021-2026 ($ million)
Exhibits 40: ROW - Year-over-year growth 2021-2026 (%)
Exhibits 41: Key leading countries
Exhibits 42: Market opportunity By Geographical Landscape ($ million)
Exhibits 43: Impact of drivers and challenges
Exhibits 44: Vendor landscape
Exhibits 45: Landscape disruption
Exhibits 46: Industry risks
Exhibits 47: Vendors covered
Exhibits 48: Market positioning of vendors
Exhibits 49: Abbott Laboratories - Overview
Exhibits 50: Abbott Laboratories - Business segments
Exhibits 51: Abbott Laboratories - Key offerings
Exhibits 52: Abbott Laboratories - Key customers
Exhibits 53: Abbott Laboratories - Segment focus
Exhibits 54: Agilent Technologies Inc. - Overview
Exhibits 55: Agilent Technologies Inc. - Business segments
Exhibits 56: Agilent Technologies Inc. - Key offerings
Exhibits 57: Agilent Technologies Inc. - Key customers
Exhibits 58: Agilent Technologies Inc. - Segment focus
Exhibits 59: Bio Rad Laboratories Inc. - Overview
Exhibits 60: Bio Rad Laboratories Inc. - Business segments
Exhibits 61: Bio Rad Laboratories Inc. - Key offerings
Exhibits 62: Bio Rad Laboratories Inc. - Key customers
Exhibits 63: Bio Rad Laboratories Inc. - Segment focus
Exhibits 64: Charles River Laboratories International Inc. - Overview
Exhibits 65: Charles River Laboratories International Inc. - Business segments
Exhibits 66: Charles River Laboratories International Inc. - Key offerings
Exhibits 67: Charles River Laboratories International Inc. - Key customers
Exhibits 68: Charles River Laboratories International Inc. - Segment focus
Exhibits 69: Eurofins Scientific SE - Overview
Exhibits 70: Eurofins Scientific SE - Business segments
Exhibits 71: Eurofins Scientific SE - Key offerings
Exhibits 72: Eurofins Scientific SE - Key customers
Exhibits 73: Eurofins Scientific SE - Segment focus
Exhibits 74: Evotec SE - Overview
Exhibits 75: Evotec SE - Business segments
Exhibits 76: Evotec SE - Key offerings
Exhibits 77: Evotec SE - Key customers
Exhibits 78: Evotec SE - Segment focus
Exhibits 79: Laboratory Corp. of America Holdings - Overview
Exhibits 80: Laboratory Corp. of America Holdings - Business segments
Exhibits 81: Laboratory Corp. of America Holdings - Key offerings
Exhibits 82: Laboratory Corp. of America Holdings - Key customers
Exhibits 83: Laboratory Corp. of America Holdings - Segment focus
Exhibits 84: Merck KGaA - Overview
Exhibits 85: Merck KGaA - Business segments
Exhibits 86: Merck KGaA - Key offerings
Exhibits 87: Merck KGaA - Key customers
Exhibits 88: Merck KGaA - Segment focus
Exhibits 89: SGS SA - Overview
Exhibits 90: SGS SA - Business segments
Exhibits 91: SGS SA - Key offerings
Exhibits 92: SGS SA - Key customers
Exhibits 93: SGS SA - Segment focus
Exhibits 94: Thermo Fisher Scientific Inc. - Overview
Exhibits 95: Thermo Fisher Scientific Inc. - Business segments
Exhibits 96: Thermo Fisher Scientific Inc. - Key offerings
Exhibits 97: Thermo Fisher Scientific Inc. - Key customers
Exhibits 98: Thermo Fisher Scientific Inc. - Segment focus
Exhibits 99: Currency conversion rates for US$
Exhibits 100: Research Methodology
Exhibits 101: Validation techniques employed for market sizing
Exhibits 102: Information sources
Exhibits 103: List of abbreviations
Executive Summary
The publisher recognizes the following companies as the key players in the global in-vitro toxicity testing market: Abbott Laboratories, Agilent Technologies Inc., Bio Rad Laboratories Inc., Charles River Laboratories International Inc., Eurofins Scientific SE, Evotec SE, Laboratory Corp. of America Holdings, Merck KGaA, SGS SA, and Thermo Fisher Scientific Inc.Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is rising number of awareness programs.`
According to the report, one of the major drivers for this market is the increasing use of in-vitro toxicity testing by companies to reduce drug failures.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Agilent Technologies Inc.
- Bio Rad Laboratories Inc.
- Charles River Laboratories International Inc.
- Eurofins Scientific SE
- Evotec SE
- Laboratory Corp. of America Holdings
- Merck KGaA
- SGS SA
- Thermo Fisher Scientific Inc.
